Literature DB >> 30070407

Reasonable patient care under uncertainty.

Charles F Manski1.   

Abstract

This paper discusses how limited ability to predict illness and treatment response may affect the welfare achieved in patient care. The discussion covers both decentralized clinical decision making and care that adheres to clinical practice guidelines. I explain why predictive ability has been limited, calling attention to questionable methodological practices in the research that supports evidence-based medicine. I summarize research on identification whose objective is to yield credible prediction of patient outcomes. Recognizing that uncertainty will continue to afflict medical decision making, I apply basic decision theory to suggest reasonable decision criteria with well-understood welfare properties. Previous research on medical decision making has largely embraced Bayesian decision theory. I summarize research studying the minimax-regret criterion, which seeks uniformly near-optimal decisions.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical guidelines; clinical judgment; evidence-based medicine; identification problems; personalized patient care; risk assessment

Mesh:

Year:  2018        PMID: 30070407     DOI: 10.1002/hec.3803

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  5 in total

1.  Discovering treatment effectiveness via median treatment effects-Applications to COVID-19 clinical trials.

Authors:  John Mullahy
Journal:  Health Econ       Date:  2021-03-05       Impact factor: 3.046

2.  Beyond the cost-effectiveness acceptability curve: The appropriateness of rank probabilities for presenting the results of economic evaluation in multiple technology appraisal.

Authors:  David Epstein
Journal:  Health Econ       Date:  2019-05-02       Impact factor: 3.046

Review 3.  Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.

Authors:  Anat R Tambur; Patricia Campbell; Anita S Chong; Sandy Feng; Mandy L Ford; Howard Gebel; Ronald G Gill; Garnett Kelsoe; Vasilis Kosmoliaptsis; Roslyn B Mannon; Michael Mengel; Elaine F Reed; Nicole M Valenzuela; Chris Wiebe; I Esme Dijke; Harold C Sullivan; Peter Nickerson
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 8.086

4.  Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs.

Authors:  Charles F Manski; Aleksey Tetenov
Journal:  Value Health       Date:  2021-03-09       Impact factor: 5.725

5.  Practicing Integrated Care Pathways in Norwegian Hospitals: Coordination through Industrialized Standardization, Value Chains, and Quality Management or an Organizational Equivalent to Improvised Jazz Standards.

Authors:  Per Magnus Mæhle; Ingrid Kristine Small Hanto; Sigbjørn Smeland
Journal:  Int J Environ Res Public Health       Date:  2020-12-09       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.